The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline
Jack F Hollis, Timothy A McAfee, Jeffrey L Fellows, Susan M Zbikowski, Michael Stark, Karen Riedlinger, Jack F Hollis, Timothy A McAfee, Jeffrey L Fellows, Susan M Zbikowski, Michael Stark, Karen Riedlinger
Abstract
Objectives: State and national tobacco quitlines have expanded rapidly and offer a range of services. We examined the effectiveness and cost effectiveness of offering callers single session versus multisession counselling, with or without free nicotine patches.
Methods: This 3x2 randomised trial included 4614 Oregon tobacco quitline callers and compared brief (one 15-minute call), moderate (one 30-minute call and a follow-up call) and intensive (five proactive calls) intervention protocols, with or without offers of free nicotine patches (nicotine replacement therapy, NRT). Blinded staff assessed tobacco use by phone at 12 months.
Results: Abstinence odds ratios were significant for moderate (OR = 1.22, CI = 1.01 to 1.48) and intensive (OR = 1.29, CI = 1.07 to 1.56) intervention, and for NRT (OR = 1.58, CI = 1.35 to 1.85). Intent to treat quit rates were as follows: brief no NRT (12%); brief NRT (17%); moderate no NRT (14%); moderate NRT (20%); intensive no NRT (14%); and intensive NRT (21%). Relative to brief no NRT, the added costs for each additional quit was $2467 for brief NRT, $1912 for moderate no NRT, $2109 for moderate NRT, $2641 for intensive no NRT, and $2112 for intensive NRT.
Conclusion: Offering free NRT and multisession telephone support within a state tobacco quitline led to higher quit rates, and similar costs per incremental quit, than less intensive protocols.
Conflict of interest statement
Competing interests: JFH, JLF and KR have no competing interests. TAMcA and SMZ are with Free & Clear, Inc, which is a for‐profit company providing telephone counselling services.
Figures
References
- Cummins S F, Bailey L, Campbell al Tobacco cessation quitlines in North America: a descriptive study. Tob Control 200716(Suppl I)i9–15.
- Miller C L, Wakefield M, Roberts L. Uptake and effectiveness of the Australian telephone Quitline service in the context of a mass media campaign. Tob Control 200312(Suppl 2)ii53–ii58.
- Wilson N, Grigg M, Graham al The effectiveness of television advertising campaigns on generating calls to a national quitline by Maori. Tob Control 200514284–286.
- Fiore M C, Croyle R T, Curry S al Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health 200494205–210.
- Ossip‐Klein D J, McIntosh S. Quitlines in North America: evidence base and applications. Am J Med Sci 2003326201–205.
- Centers for Disease Control and Prevention Telephone quitlines: a resource for development, implementation, and evaluation. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004
- Fiore M C, Bailey W C, Cohen S alTreating tobacco use and dependence: a clinical practice guideline. Rockville, MD: United States Department of Health and Human Services, 2000
- Hughes J R, Shiffman S, Callas al A meta‐analysis of the efficacy of over‐the‐counter nicotine replacement. Tob Control 20031221–27.
- Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2004;CD000031
- Gonzales D, Rennard S I, Nides al Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained‐release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 200629647–55.
- Jorenby D E, Hays J T, Rigotti N al Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained‐release bupropion for smoking cessation: a randomized controlled trial. JAMA 200629656–63.
- Tonstad S, Tonnesen P, Hajek al Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 200629664–71.
- Lichtenstein E, Glasgow R E, Lando H al Telephone counseling for smoking cessation: rationales and meta‐analytic review of evidence. Health Educ Res 199611243–257.
- Hopkins D P, Briss P A, Ricard C al Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 20012016–66.
- Stead L F, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob Control 200716(Suppl I)3–8.
- Stead L F, Lancaster T, Perera R. Telephone counseling for smoking cessation. Cochrane Database Syst Rev 200619
- Borland R, Segan C J, Livingston P al The effectiveness of callback counseling for smoking cessation: a randomized trial. Addiction 200196881–889.
- Zhu S H, Anderson C M, Tedeschi G al Evidence of real‐world effectiveness of a telephone quitline for smokers. N Engl J Med 20023471087–1093.
- McAlister A L, Rabius V, Geiger al Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob Control 20041385–86.
- Smith P M, Cameron R, McDonald P al Telephone counseling for population‐based smoking cessation. Am J Health Behav 200428231–241.
- Zhu S H, Anderson C M, Johnson C al A centralised telephone service for tobacco cessation: the California experience. Tob Control 20009(Suppl 2)ii48–ii55.
- McAfee T, Sofian N S, Wilson al The role of tobacco intervention in population‐based health care: a case study. Am J Prev Med 19981446–52.
- Borland R, Balmford J, Segan al The effectiveness of personalized smoking cessation strategies for callers to a quitline service. Addiction 200398837–846.
- Zhu S H, Stretch V, Balabanis al Telephone counseling for smoking cessation: effects of single‐session and multiple‐session interventions. J Consult Clin Psychol 199664202–211.
- Gilbert H, Sutton S. Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial. Addiction 2006101590–598.
- Swan G E, McAfee T, Curry S al Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med 20031632337–2344.
- Zhu S H, Tedeschi G, Anderson C al Telephone counseling as adjuvant treatment for nicotine replacement therapy in a “real‐world” setting. Prev Med 200031357–363.
- Macleod Z R, Charles M A, Arnaldi V al Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial. Med J Aust 2003179349–352.
- Reid R D, Pipe A, Dafoe W A. Is telephone counselling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial. CMAJ 19991601577–1581.
- Halpin H A, McMenamin S B, Rideout al The costs and effectiveness of different benefit designs for treating tobacco dependence: results from a randomized trial. Treating Tobacco Dependence 20064354–65.
- Solomon L J, Scharoun G M, Flynn B al Free nicotine patches plus proactive telephone peer support to help low‐income women stop smoking. Prev Med 20003168–74.
- Cummings K M, Hyland A, Fix al Free nicotine patch giveaway program 12‐month follow‐up of participants. Am J Prev Med 200631181–184.
- Tunis S R, Stryer D B, Clancy C M. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA 20032901624–1632.
- Rollnick S. What is motivational interviewing? Motivational Interviewing Newsletter for Trainers 19952(Issue 3)1–8.
- Rollnick S, Miller W. What is motivational interviewing? Behavioral Cognitive Psychotherapy 199523325–334.
- Miller W, Rollnick S.Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press, 1991
- Schafer J L, Graham J W. Missing data: our view of the state of the art. Psychol Methods 20027147–177.
- Solas V. 3.0. Cork, Ireland: Statistical Solutions, Ltd. 2001
- US Department of Labor Bureau of Labor Statistics. Available at http:
- Fix B, Carlin S, Celestino al Free NRT programs: a report on the reach, efficacy, and cost‐effectiveness of NRT give away programs conducted in New York state, 2004
- An L C, Schillo B A, Kavanaugh al Access to nicotine replacement therapy as part of a statewide tobacco telephone helpline. Am J Health Promotion 200620267–271.
- Miller N, Frieden T R, Liu S al Effectiveness of a large‐scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 20053651849–1854.
- Swartz S H, Cowan T M, Klayman J al Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med 200529288–294.
- Cummings K M, Fix B, Celestino al Reach, efficacy, and cost‐effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract 20061237–43.
- Bush T, Zbikowski S M, McClure al Treatment utilization and adherence in a telephonic tobacco cessation program. Proc National Conference on Tobacco or Health 2003
- Hall S M, Delucchi K L, Velicer W al Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcome. Nicotine Tob Res 20013193–202.
- Glasgow R E, Mullooly J P, Vogt T al Biochemical validation of smoking status: pros, cons, and data from four low‐intensity intervention trials. Addict Behav 199318511–527.
- Velicer W F, Prochaska J O, Rossi J al Assessing outcome in smoking cessation studies. Psychol Bull 199211123–41.
- Patrick D L, Cheadle A, Thompson D al The validity of self‐reported smoking: a review and meta‐analysis. Am J Public Health 1994841086–1093.
- SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine Tob Res 20024149–159.
- Fu S S, Partin M R, Snyder al Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care 200612235–243.
- McAfee T A. Managed care and the state tobacco settlements. Tob Control 20009(Suppl 1)I17
- Schroeder S A. What to do with a patient who smokes. JAMA 2005294482–487.
Source: PubMed